Generex Awarded Two New Patents for its Proprietary Buccal Drug Delivery System
The Commissioner of the Japan Patent Office granted the Company a patent titled ”Mixed Micellar Pharmaceutical Delivery System and Method of Preparation”. Patent number 449282 is registered in the Japan Patent Office.
The Ukrainian State Register of patents and inventions granted the Company patent number 90346 entitled “Orally absorbed pharmaceutical formulation and method of administration.”
These new patents increase the number of issued patents related to the Company’s buccal drug delivery platform technologies to 160. A total of 103 patent applications are pending.
“Each new patent issuance establishes the inventiveness of the Company’s buccal drug delivery platform technologies”, stated Rose C. Perri, the Company’s Chief Operating Officer. “We are pleased that we continue to receive patents from key markets within which our delivery system can be commercialized with a pipeline of viable applications that will open up other marketplaces for the Company”.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.